Ubs Group Ag Immuno Precise Antibodies Ltd. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 6,266 shares of IPA stock, worth $12,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,266

Previous 7,559 17.11%

Holding current value

$12,657

Previous $2,000 200.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.34 - $1.11 $439 - $1,435	-1,293 Reduced 17.11%	6,266 $6,000
Q1 2025 May 13, 2025	BUY	$0.28 - $0.64 $2,116 - $4,837	7,559 New	7,559 $2,000
Q2 2024 Aug 13, 2024	BUY	$0.98 - $1.53 $9,558 - $14,923	9,754 Added 393.62%	12,232 $12,000
Q1 2024 May 13, 2024	SELL	$1.4 - $2.41 $11,482 - $19,766	-8,202 Reduced 76.8%	2,478 $3,000
Q4 2023 Feb 09, 2024	BUY	$1.11 - $2.3 $11,777 - $24,402	10,610 Added 15157.14%	10,680 $18,000
Q3 2023 Nov 09, 2023	BUY	$1.76 - $3.04 $123 - $212	70 New	70 $0
Q4 2022 Feb 08, 2023	BUY	$4.5 - $5.72 $7,006 - $8,906	1,557 Added 5190.0%	1,587 $8,000
Q3 2022 Nov 10, 2022	SELL	$3.77 - $6.39 $13,440 - $22,780	-3,565 Reduced 99.17%	30 $0
Q2 2022 Aug 10, 2022	BUY	$3.8 - $6.08 $13,661 - $21,857	3,595 New	3,595 $14,000
Q1 2022 May 16, 2022	SELL	$3.64 - $6.49 $14,509 - $25,869	-3,986 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.06 - $6.69 $4,984 - $6,589	985 Added 32.82%	3,986 $21,000
Q3 2021 Nov 15, 2021	BUY	$5.14 - $13.22 $128 - $330	25 Added 0.84%	3,001 $18,000
Q2 2021 Aug 13, 2021	BUY	$6.02 - $12.91 $10,498 - $22,515	1,744 Added 141.56%	2,976 $18,000
Q1 2021 May 12, 2021	BUY	$8.84 - $17.0 $10,890 - $20,944	1,232 New	1,232 $12,000

Others Institutions Holding IPA

# of Institutions

Shares Held

Call Options Held

77.9K

Put Options Held

View Full List

About ImmunoPrecise Antibodies Ltd.

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $50.2M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

More about IPA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account